• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房患者无症状导管相关血栓形成的发生率:一项前瞻性队列研究。

Incidence of asymptomatic catheter-related thrombosis in intensive care unit patients: a prospective cohort study.

作者信息

Abbruzzese Chiara, Guzzardella Amedeo, Consonni Dario, Turconi Gloria, Bonetti Claudia, Brioni Matteo, Panigada Mauro, Grasselli Giacomo

机构信息

Department of Anaesthesiology, Critical Care and Emergency, Intensive Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza, 35, 20122, Milan, Italy.

Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza, 35, 20122, Milan, Italy.

出版信息

Ann Intensive Care. 2023 Oct 19;13(1):106. doi: 10.1186/s13613-023-01206-w.

DOI:10.1186/s13613-023-01206-w
PMID:37858003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10587047/
Abstract

BACKGROUND

Catheter-related thrombosis (CRT) incidence, rate, and risk factors vary in literature due to differences in populations, catheters, diagnostic methods, and statistical approaches. The aim of this single-center, prospective, observational study was to assess incidence, incidence rate (IR), cumulative incidence, and risk factors by means of IR ratio (IRR) of asymptomatic CRT in a non-oncologic Intensive Care Unit (ICU) population. CRT development was assessed daily by means of ultrasound screening. The proportions of patients and catheters developing CRT and CRT incidence rates, expressed as the number of events per catheter-days (cd), were calculated. Kalbfleisch and Prentice's method was used to estimate the cumulative incidence of CRTs. Univariate and multivariable Poisson regression models were fitted to calculate IRR in risk factors analysis.

RESULTS

Fifty (25%, 95% CI 19-31) out of 203 included patients, and 52 (14%, 95% CI 11-18) out of 375 catheters inserted developed CRT [IR 17.7 (13.5-23.2) CRTs/1000cd], after 5 [3-10] days from insertion. Forty-six CRTs (88%) were partial thrombosis. All CRTs remained asymptomatic. Obesity and ECMO support were patient-related protective factors [IRR 0.24 (0.10-0.60), p = 0.002 and 0.05 (0.01-0.50), p = 0.011, respectively]. The internal jugular vein had higher CRT IR than other sites [20.1 vs. 5.9 CRTs/1000cd, IRR 4.22 (1.22-14.63), p = 0.023]. Pulmonary artery catheter and left-side cannulation were catheter-related risk factors [IRR 4.24 (2.00-9.00), p < 0.001 vs. central venous catheters; IRR 2.69 (1.45-4.98), p = 0.002 vs. right cannulation, respectively]. No statistically significant effect of the number of simultaneously inserted catheters [IRR 1.11 (0.64-1.94), p = 0.708] and of the catheterization length [IRR 1.09 (0.97-1.22), p = 0.155] was detected. The ICU length of stay was longer in CRT patients (20 [15-31] vs. 6 [4-14] days, p < 0.001), while no difference in mortality was observed.

CONCLUSIONS

CRTs are frequent but rarely symptomatic. This study suggests that obesity and ECMO are protective factors, while pulmonary artery catheter, internal jugular vein and left-side positioning are risk factors for CRT.

摘要

背景

由于研究人群、导管、诊断方法和统计方法的差异,文献中导管相关血栓形成(CRT)的发生率、发病率及危险因素各不相同。本单中心、前瞻性、观察性研究旨在通过非肿瘤重症监护病房(ICU)人群中无症状CRT的发病率比(IRR)来评估其发生率、发病率、累积发病率及危险因素。通过超声筛查每日评估CRT的发生情况。计算发生CRT的患者和导管比例以及CRT发病率,以每导管日(cd)的事件数表示。采用卡尔弗莱施和普伦蒂斯方法估计CRT的累积发病率。在危险因素分析中,采用单变量和多变量泊松回归模型计算IRR。

结果

203例纳入患者中有50例(25%,95%CI 19 - 31),375根插入导管中有52根(14%,95%CI 11 - 18)发生CRT [发病率为17.7(13.5 - 23.2)例CRT/1000cd],发生在插入导管后5 [3 - 10]天。46例CRT(88%)为部分血栓形成。所有CRT均无症状。肥胖和体外膜肺氧合(ECMO)支持是与患者相关的保护因素[IRR分别为0.24(0.10 - 0.60),p = 0.002和0.05(0.01 - 0.50),p = 0.011]。颈内静脉的CRT发病率高于其他部位[20.1 vs. 5.9例CRT/1000cd,IRR 4.22(1.22 - 14.63),p = 0.023]。肺动脉导管和左侧置管是与导管相关的危险因素[与中心静脉导管相比,IRR 4.24(2.00 - 9.00),p < 0.001;与右侧置管相比,IRR 2.69(1.45 - 4.98),p = 0.002]。未检测到同时插入导管数量[IRR 1.11(0.64 - 1.94),p = 0.708]和置管长度[IRR 1.09(0.97 - 1.22),p = 0.155]的统计学显著影响。CRT患者的ICU住院时间更长(20 [15 - 31]天 vs. 6 [4 - 14]天,p < 0.001),但死亡率无差异。

结论

CRT很常见,但很少有症状。本研究表明肥胖和ECMO是保护因素,而肺动脉导管、颈内静脉和左侧置管是CRT的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b725/10587047/65e60a609f1c/13613_2023_1206_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b725/10587047/81b258459747/13613_2023_1206_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b725/10587047/65e60a609f1c/13613_2023_1206_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b725/10587047/81b258459747/13613_2023_1206_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b725/10587047/65e60a609f1c/13613_2023_1206_Fig2_HTML.jpg

相似文献

1
Incidence of asymptomatic catheter-related thrombosis in intensive care unit patients: a prospective cohort study.重症监护病房患者无症状导管相关血栓形成的发生率:一项前瞻性队列研究。
Ann Intensive Care. 2023 Oct 19;13(1):106. doi: 10.1186/s13613-023-01206-w.
2
Catheter-related thrombosis after cardiac surgery in patients with both central venous and pulmonary artery catheters inserted into the right internal jugular vein: a single-center, prospective, observational study.经右颈内静脉插入中心静脉导管和肺动脉导管的心脏手术患者导管相关血栓形成:一项单中心、前瞻性、观察性研究。
Heart Vessels. 2022 Apr;37(4):691-696. doi: 10.1007/s00380-021-01955-3. Epub 2021 Oct 7.
3
Daily point-of-care ultrasound-assessment of central venous catheter-related thrombosis in critically ill patients: a prospective multicenter study.危重症患者中心静脉导管相关血栓形成的每日床旁超声评估:一项前瞻性多中心研究。
Intensive Care Med. 2023 Apr;49(4):401-410. doi: 10.1007/s00134-023-07006-x. Epub 2023 Mar 9.
4
[Risk factors analysis of central venous catheter-related thrombosis in critically ill patients and development of nomogram prediction model].[危重症患者中心静脉导管相关血栓形成的危险因素分析及列线图预测模型的构建]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Sep;33(9):1047-1051. doi: 10.3760/cma.j.cn121430-20210712-01044.
5
The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population.重症监护病房人群中锁骨下、颈内静脉和股静脉部位中心静脉导管感染并发症的发生率。
Crit Care Med. 2005 Jan;33(1):13-20; discussion 234-5. doi: 10.1097/01.ccm.0000149838.47048.60.
6
Central venous catheter-related thrombosis in pediatric surgical patients: A prospective observational study.小儿外科患者中心静脉导管相关性血栓形成:一项前瞻性观察研究。
Paediatr Anaesth. 2022 Apr;32(4):563-571. doi: 10.1111/pan.14346. Epub 2021 Dec 5.
7
Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters.急性白血病患者导管相关血栓形成的发生率:一项关于外周静脉置入与中心静脉置入中心静脉导管安全性的比较性回顾性研究。
Ann Hematol. 2016 Dec;95(12):2057-2064. doi: 10.1007/s00277-016-2798-4. Epub 2016 Aug 20.
8
[Exploration of the high-risk factors of catheter-related thrombosis in breast cancer].[乳腺癌导管相关血栓形成高危因素的探讨]
Zhonghua Zhong Liu Za Zhi. 2021 Aug 23;43(8):838-842. doi: 10.3760/cma.j.cn112152-20200226-00131.
9
Early-onset thrombosis of internal jugular vein associated with introducer catheter for heart catheterization in cardiac surgery.心脏手术中与心导管插入术导入导管相关的颈内静脉早发性血栓形成。
J Vasc Access. 2015 Jan-Feb;16(1):57-63. doi: 10.5301/jva.5000303. Epub 2014 Sep 2.
10
Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children.儿童外周置入中心静脉导管相关的浅静脉和深静脉血栓形成的发生率和危险因素。
J Thromb Haemost. 2016 Nov;14(11):2158-2168. doi: 10.1111/jth.13478. Epub 2016 Oct 12.

引用本文的文献

1
The preparation of amphiphilic carbonaceous particle-derived membranes as a potent sterilant and anticoagulant.两亲性碳质颗粒衍生膜作为一种高效杀菌剂和抗凝剂的制备
RSC Adv. 2025 Aug 26;15(37):30339-30346. doi: 10.1039/d5ra01833a. eCollection 2025 Aug 22.
2
Poly(hydroxy-oxazolidone) Thermoplastic Elastomers for Safer, Greener and Customizable Blood-Contacting Medical Devices.用于更安全、更环保且可定制的血液接触医疗设备的聚(羟基恶唑烷酮)热塑性弹性体。
Adv Healthc Mater. 2025 Sep;14(23):e2502670. doi: 10.1002/adhm.202502670. Epub 2025 Jun 19.
3
Recombinant neorudin and its active metabolite hirudin: the fate of a novel anticoagulant drug.

本文引用的文献

1
Curing coma: facing the real-world challenges.治愈昏迷:面对现实世界的挑战。
Intensive Care Med. 2023 Aug;49(8):1025-1026. doi: 10.1007/s00134-023-07144-2. Epub 2023 Jun 23.
2
Central venous catheter-associated deep vein thrombosis in critically ill pediatric patients: risk factors, prevention, and treatment.危重症患儿中心静脉导管相关的深静脉血栓形成:危险因素、预防和治疗。
Curr Opin Pediatr. 2022 Jun 1;34(3):273-278. doi: 10.1097/MOP.0000000000001128.
3
Risk factors associated with catheter-related venous thrombosis: a meta-analysis.
重组水蛭素及其活性代谢产物水蛭素:一种新型抗凝药物的转归
Front Pharmacol. 2024 Sep 17;15:1443475. doi: 10.3389/fphar.2024.1443475. eCollection 2024.
4
Catheter-related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs.导管相关深静脉血栓形成:我们目前的状况及未来走向?最新进展与尚未满足的临床需求
Eur J Clin Invest. 2025 Jan;55(1):e14311. doi: 10.1111/eci.14311. Epub 2024 Sep 12.
与导管相关的静脉血栓形成的相关危险因素:一项荟萃分析。
Public Health. 2022 Apr;205:45-54. doi: 10.1016/j.puhe.2022.01.018. Epub 2022 Feb 26.
4
Symptomatic pulmonary embolus after catheter removal in children with catheter related thrombosis: A report from the CHAT Consortium.儿童导管相关血栓形成后导管取出后出现症状性肺栓塞:来自 CHAT 联盟的报告。
J Thromb Haemost. 2022 Jan;20(1):133-137. doi: 10.1111/jth.15548. Epub 2021 Oct 19.
5
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态:血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
6
Central venous catheter-related thrombosis in children and adults.儿童和成人的中心静脉导管相关性血栓形成。
Thromb Res. 2020 Mar;187:103-112. doi: 10.1016/j.thromres.2020.01.017. Epub 2020 Jan 15.
7
Best Practice for Delivering Small-Volume Intermittent Intravenous Infusions.小容量间歇性静脉输液的最佳实践
J Infus Nurs. 2020 Jan/Feb;43(1):47-52. doi: 10.1097/NAN.0000000000000355.
8
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
9
Rapid Central Vein Assessment (RaCeVA): A systematic, standardized approach for ultrasound assessment before central venous catheterization.快速中心静脉评估(RaCeVA):一种用于中心静脉置管前超声评估的系统、标准化方法。
J Vasc Access. 2019 May;20(3):239-249. doi: 10.1177/1129729818804718. Epub 2018 Oct 4.
10
Complication and Failures of Central Vascular Access Device in Adult Critical Care Settings.成人重症监护环境中心血管通路装置的并发症和失败。
Crit Care Med. 2018 Dec;46(12):1998-2009. doi: 10.1097/CCM.0000000000003370.